Dorin Toader

6PUBLICATIONS
67CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsBiologically active moleculesCharacterisation of biological macromoleculesPharmaceutical delivery technologiesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 31, 2025
PBPK Modeling to Predict Clinical Drug-Drug Interaction and Impact of Hepatic Impairment for an ADC With the Payload Auristatin F-Hydroxypropylamide.

Niyanta Kumar, Vaishali Dixit, Howard Burt

|Mar 03, 2025
XMT-2056, a HER2-Directed STING Agonist Antibody-Drug Conjugate, Induces Innate Antitumor Immune Responses by Acting on Cancer Cells and Tumor-Resident Immune Cells.

Raghida A Bukhalid, Jeremy R Duvall, Kelly Lancaster

|Feb 14, 2024
Development of a Novel DNA Mono-alkylator Platform for Antibody-Drug Conjugates.

Joshua D Thomas, Aleksandr V Yurkovetskiy, Mao Yin

|Sep 29, 2023
Site-Specific Dolasynthen Antibody-Drug Conjugates Exhibit Consistent Pharmacokinetic Profiles across a Wide Range of Drug-to-Antibody Ratios.

Susan M Clardy, Alex Uttard, Bingfan Du

|Jun 09, 2023
Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody-Drug Conjugate for the Treatment of Cancer.

Dorin Toader, Shawn P Fessler, Scott D Collins

|Jun 02, 2018
Discovery and Optimization of a Novel Series of Highly Selective JAK1 Kinase Inhibitors.

Neil P Grimster, Erica Anderson, Marat Alimzhanov

Pageof 1

Frequent Collaborators

5 joint publications

Timothy B Lowinger

4 joint publications

Ling Xu

4 joint publications

Kalli C Catcott

4 joint publications

Marc Damelin